Update on management of epilepsy in women for the non-neurologist

Postgraduate Medical Journal

Volumn 92, Issue 1091, 2016, Pages 554-559

  Gooneratne, Inuka Kishara ^a   Wimalaratna, Sunil ^a,b  

^a KETTERING GENERAL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; CYTOCHROME P450; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SEX HORMONE; VITAMIN K GROUP; ANTICONVULSIVE AGENT; ORAL CONTRACEPTIVE AGENT;

BREAST FEEDING; CATAMENIAL EPILEPSY; CONTRACEPTION; ENZYME ACTIVITY; EPILEPSY; FEMALE FERTILITY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; NEUROLOGIST; POSTPARTUM HEMORRHAGE; PREGNANCY; PULMONARY HYPERTENSION; REVIEW; SEIZURE; TERATOGENICITY; ABNORMALITIES, DRUG-INDUCED; DRUG INTERACTION; ESTROGEN THERAPY; FEMALE; PATHOPHYSIOLOGY; PERIODICITY; PREGNANCY COMPLICATIONS;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; BREAST FEEDING; CONTRACEPTIVES, ORAL, HORMONAL; DRUG INTERACTIONS; EPILEPSY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MENOPAUSE; MENSTRUAL CYCLE; PERIODICITY; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84978886180     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2016-134191     Document Type: Review

References (50)

1. Forsgren L, Beghi E, Oun A, et al. The epidemiology of epilepsy in Europe-a systematic review. Eur J Neurol 2005;12:245-53.
2. O’Brien MD, Gilmour-White SK. Management of epilepsy in women. Postgrad Med J 2005;81:278-85.
3. Thomas SV. Controversies in contraception for women with epilepsy. Ann Indian Acad Neurol 2015;18:278-83.
4. Patsalos PN, Fröscher W, Pisani F, et al. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365-85.
5. Garnett WR. Clinical pharmacology of topiramate: a review. Epilepsia 2000;41 (Suppl 1):61-5.
6. Guillebaud J. Contraception: your questions answered. 4th edn. Edinburgh: Churchill Livingstone, 2004:122.
7. Morrell MJ. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy and fetal outcome. Epilepsia 1996;37(Suppl 6):S34-44.
8. Sabers A, Buchholt JM, Uldall P, et al. Lamotrigine plasma levels reduced by oral contraceptives. Epilepsy Res 2001;47:151-4.
9. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082-8.
10. Najafi M, Sadeghi MM, Mehvari J, et al. Progesterone therapy in women with intractable catamenial epilepsy. Adv Biomed Res 2013;2:8.
11. Herzog AG. Catamenial epilepsy: update on prevalence, pathophysiology and treatment from the findings of the NIH Progesterone Treatment Trial. Seizure 2015;28:18-25.
12. Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet 2015;386:1845-52.
13. Sveberg L, Svalheim S, Taubøll E. The impact of seizures on pregnancy and delivery. Seizure 2015;28:35-8.
14. Dubovický M. Neurobehavioral manifestations of developmental impairment of the brain. Interdiscip Toxicol 2010;3:59-67.
15. Lima DC, Vale TG, Arganãraz GA, et al. Behavioral evaluation of adult rats exposed in utero to maternal epileptic seizures. Epilepsy Behav 2010;18:45-9.
16. Tomson T, Hiilesmaa V. Epilepsy in pregnancy. BMJ 2007;335:769-73.
17. Battino D, Tomson T, Bonizzoni E, et al, EURAP Study Group. Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry. Epilepsia 2013;54:1621-7.
18. Vajda FJ, O’Brien TJ, Graham J, et al. The outcomes of pregnancy in women with untreated epilepsy. Seizure 2015;24:77-81.
19. Meador KJ. Epilepsy: Pregnancy in women with epilepsy-risks and management. Nat Rev Neurol 2014;10:614-16.
20. Laganà AS, Triolo O, D’Amico V, et al. Management of women with epilepsy: from preconception to post-partum. Arch Gynecol Obstet 2016;293:493-503.
21. Koch S, Lösche G, Jager-Romän E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992;42(Suppl 5):83-8.
22. Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17.
23. Tomson T, Battino D, Perucca E. Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug. Lancet Neurol 2015;15:210-8.
24. Vajda FJ. Effect of anti-epileptic drug therapy on the unborn child. J Clin Neurosci 2014;21:716-21.
25. Reimers A. New antiepileptic drugs and women. Seizure 2014;23:585-91.
26. Tomson T, Battino D. Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 2007;46:209-19.
27. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatr 2006;77:193-8.
28. Women and girls with epilepsy. Epilepsies: diagnosis and management. Published: 11 January 2012. http://www.nice.org.uk/guidance/cg137/resources/epilepsies-diagnosis-and-management (accessed 2.3.2016).
29. Bromley RL, Baker GA, Meador KJ. Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol 2009;22:162-6.
30. Tran TA, Leppik IE, Blesi K, et al. Lamotrigine clearance during pregnancy. Neurology 2002;59:251-5.
31. Brodtkorb E, Reimers A. Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure 2008;17:160-5.
32. Pennell PB. Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 2003;61:S35-42.
33. Parry E, Shields R, Turnbull AC. The effect of pregnancy on the colonic absorption of sodium, potassium and water. J Obstet Gynaecol Br Commonw 1970;77:616-19.
34. Messmer K, Kemming G. Clinical hemodilution. In: Winslow RM, ed. Blood Substitutes 2006:178-87.
35. Davison JM, Dunlop W. Renal hemodynamics and tubular function in normal human pregnancy. Kidney Int 1980;18:152-61.
36. Reisinger TL, Newman M, Loring DW, et al. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Epilepsy Behav 2013;29:13-18.
37. Vajda FJ, O’Brien T, Lander C, et al. The efficacy of the newer antiepileptic drugs in controlling seizures in pregnancy. Epilepsia 2014;55:1229-34.
38. MRC Vitamin Study Research Group. Prevention of neural tube defects; results of the Medical Research Council vitamin study. Lancet 1991;338:132-7.
39. Biale Y, Lewenthal M. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur J Obstet Gynecol Reprod Biol 1984;18:211-16.
40. Moore JL. The significance of folic acid for epilepsy patients. Epilepsy Behav 2005;7:172-81.
41. Genetics Committee, Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. The use of folic acid for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can 2003;25:959-73.
42. Kaaja E, Kaaja R, Matila R, et al. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology 2002;58:549-53.
43. Harden CL, Pulver MC, Ravdin L, et al. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999;40:1402-7.
44. Rościzewska D. Menopause in women and its effects on epilepsy. Neurol Neurochir Pol 1978;12:315-19.
45. Abbasi F, Krumholz A, Kittner SJ, et al. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999;40:205-10.
46. Erel T, Guralp O. Epilepsy and menopause. Arch Gynecol Obstet 2011;284:749-55.
47. Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006;47:1447-51.
48. Persson HB, Alberts KA, Farahmand BY, et al. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 2002;43:768-72.
49. Harden CL. Menopause and bone density issues for women with epilepsy. Neurology 2003;61(Suppl 2):S16-22.
50. MHRA. Antiepileptics: adverse effects on bone. Drug Saf Update 2009;2:2-12.